AlzeCure Pharma AB (publ)

OM:ALZCUR Stock Report

Market Cap: SEK 144.4m

AlzeCure Pharma Management

Management criteria checks 3/4

AlzeCure Pharma's CEO is Martin Jönsson, appointed in Jan 2020, has a tenure of 4.83 years. total yearly compensation is SEK2.48M, comprised of 76.6% salary and 23.4% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth SEK669.48K. The average tenure of the management team and the board of directors is 4.8 years and 3.5 years respectively.

Key information

Martin Jönsson

Chief executive officer

SEK 2.5m

Total compensation

CEO salary percentage76.6%
CEO tenure4.8yrs
CEO ownership0.5%
Management average tenure4.8yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

We Think AlzeCure Pharma (STO:ALZCUR) Can Afford To Drive Business Growth

Dec 02
We Think AlzeCure Pharma (STO:ALZCUR) Can Afford To Drive Business Growth

Companies Like AlzeCure Pharma (STO:ALZCUR) Can Afford To Invest In Growth

Jul 20
Companies Like AlzeCure Pharma (STO:ALZCUR) Can Afford To Invest In Growth

Will AlzeCure Pharma (STO:ALZCUR) Spend Its Cash Wisely?

Oct 12
Will AlzeCure Pharma (STO:ALZCUR) Spend Its Cash Wisely?

Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Jan 03
Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Jul 12
Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Mar 28
Is AlzeCure Pharma (STO:ALZCUR) In A Good Position To Invest In Growth?

Need To Know: AlzeCure Pharma AB (publ) (STO:ALZCUR) Insiders Have Been Buying Shares

Feb 03
Need To Know: AlzeCure Pharma AB (publ) (STO:ALZCUR) Insiders Have Been Buying Shares

We're Not Very Worried About AlzeCure Pharma's (STO:ALZCUR) Cash Burn Rate

Dec 13
We're Not Very Worried About AlzeCure Pharma's (STO:ALZCUR) Cash Burn Rate

CEO Compensation Analysis

How has Martin Jönsson's remuneration changed compared to AlzeCure Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 36m

Jun 30 2024n/an/a

-SEK 36m

Mar 31 2024n/an/a

-SEK 37m

Dec 31 2023SEK 2mSEK 2m

-SEK 37m

Sep 30 2023n/an/a

-SEK 38m

Jun 30 2023n/an/a

-SEK 42m

Mar 31 2023n/an/a

-SEK 53m

Dec 31 2022SEK 2mSEK 2m

-SEK 56m

Sep 30 2022n/an/a

-SEK 68m

Jun 30 2022n/an/a

-SEK 73m

Mar 31 2022n/an/a

-SEK 67m

Dec 31 2021SEK 2mSEK 2m

-SEK 78m

Sep 30 2021n/an/a

-SEK 73m

Jun 30 2021n/an/a

-SEK 78m

Mar 31 2021n/an/a

-SEK 81m

Dec 31 2020SEK 2mSEK 1m

-SEK 71m

Compensation vs Market: Martin's total compensation ($USD227.04K) is about average for companies of similar size in the Swedish market ($USD237.78K).

Compensation vs Earnings: Martin's compensation has increased whilst the company is unprofitable.


CEO

Martin Jönsson (56 yo)

4.8yrs

Tenure

SEK 2,475,000

Compensation

Mr. Martin Jönsson is the Chief Executive Officer of AlzeCure Pharma AB (publ) since January 8, 2020. Mr. Jönsson served in a senior position at Ferring Pharmaceuticals in the US, he was business area dire...


Leadership Team

NamePositionTenureCompensationOwnership
Martin Jönsson
Chief Executive Officer4.8yrsSEK 2.48m0.46%
SEK 669.5k
Birgitta Lundvik
Chief Financial Officer7.8yrsno data0.14%
SEK 200.3k
Johan Sandin
Chief Scientific Officer4.8yrsSEK 1.28m0.99%
SEK 1.4m
Marta Storck
Chief Medical Officer & Head of Development3.6yrsno data0.084%
SEK 121.3k
Pontus Forsell
Head of Research & Discovery7.8yrsno data1.03%
SEK 1.5m

4.8yrs

Average Tenure

57yo

Average Age

Experienced Management: ALZCUR's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Pollare
Chairman7.8yrsSEK 229.00k1.7%
SEK 2.5m
Jan Lundberg
Directorless than a yearno datano data
Ragnar Linder
Independent Director7.8yrsSEK 115.00k0.056%
SEK 81.3k
John Harrison
Scientific Advisorno datano datano data
Bengt Winblad
Scientific Advisorno datano datano data
Peter Snyder
Scientific Advisorno datano datano data
Henrik Zetterberg
Scientific Advisorno datano datano data
Rolf Karlsten
Scientific Advisorno datano datano data
Janet Hoogstraate
Independent Director1.5yrsSEK 73.00k0.028%
SEK 40.9k
Sven Ogren
Scientific Advisorno datano datano data
Eva Lilienberg
Independent Director3.5yrsSEK 115.00k0.0028%
SEK 4.1k

3.5yrs

Average Tenure

70yo

Average Age

Experienced Board: ALZCUR's board of directors are considered experienced (3.5 years average tenure).